CBD does not get you high. Unlike THC, the compound in cannabis responsible for intoxication, CBD has little ability to activate the brain receptors that produce a high. Even at doses as large as 1,500 mg per day (far beyond what most people take), clinical trials report no intoxicating effects. What CBD can do, however, is come packaged alongside small amounts of THC in certain product types, and that’s where the picture gets more complicated.
Why CBD Can’t Produce a High
THC creates its psychoactive effects by binding strongly to CB1 receptors in the brain, the same receptors involved in mood, memory, and motor control. CBD has very little binding affinity for these receptors. Instead of activating them, CBD actually works against THC at those sites. It acts as a negative allosteric modulator of CB1 receptors, which means it changes the shape of the receptor in a way that makes THC less effective. So CBD doesn’t just fail to get you high; it actively dampens THC’s ability to do so when both compounds are present.
What CBD Actually Feels Like
People sometimes describe feeling “something” after taking CBD, and that’s not imaginary. In a controlled study comparing CBD-dominant and THC-dominant cannabis concentrates, the CBD group reported immediate decreases in tension and anxiety, along with a mild bump in positive mood. The THC group, by contrast, experienced significantly higher intoxication, paranoia spikes, and a much stronger sense of being “high.”
The key difference: CBD’s effects were subtle and calming, not intoxicating. There was no paranoia, no impaired thinking, and no feeling of being altered. At high clinical doses (600 to 1,500 mg per day), the most commonly reported side effects are digestive issues like diarrhea and stomach discomfort, fatigue, and occasional drowsiness. Some people in trials taking 800 mg reported mild lethargy or wooziness. These are side effects, not a high, and they occur at doses many times larger than what’s in a typical consumer product.
The Trace THC Problem
Here’s the important caveat: many CBD products contain small amounts of THC, and those amounts aren’t always as small as the label suggests. Under federal law, hemp-derived CBD products can contain up to 0.3% THC by dry weight. That sounds negligible, but in practice it adds up depending on the product type, concentration, and how much you take.
A lab analysis of commercially available CBD products found THC concentrations in full-spectrum products ranging from 0.051 mg/mL to 2.071 mg/mL. If you took 1 mL of the average product three times a day, you’d consume about 1.86 mg of THC daily. With the highest-concentration product at that same dose, you’d get 6.2 mg of THC per day. For reference, the standard research dose of THC used by the National Institute on Drug Abuse is 5 mg, and the starting dose for a prescription synthetic THC medication is 2.5 mg. That means some full-spectrum CBD products can deliver pharmacologically meaningful amounts of THC without any warning on the label.
Product labeling is also unreliable. In one analysis of 202 CBD products, 74% deviated from their labeled CBD content by at least 10%. More concerning, some broad-spectrum products (which are supposed to have THC removed) still contained THC, with two exceeding the 0.3% legal limit. One product even claimed “No THC” on the label but tested positive for it.
Three Product Types, Three Risk Levels
- CBD isolate contains only CBD with no other cannabis compounds. This carries the lowest risk of any THC exposure, though mislabeling remains possible.
- Broad-spectrum CBD includes other plant compounds but is supposed to have THC removed. In practice, some products still contain detectable THC.
- Full-spectrum CBD intentionally contains trace THC (up to 0.3%). At higher doses or with more concentrated products, the THC exposure can become significant enough to matter.
Drug Testing Risks
Pure CBD, taken on its own, does not trigger a positive drug test under current federal workplace testing guidelines. That finding comes from controlled pharmacokinetic studies where participants took CBD with no THC contamination.
But real-world CBD products are a different story. In one study, participants who vaped a CBD-dominant cannabis product containing just 0.39% THC (barely above the legal hemp threshold) saw some positive drug tests. Three of 18 participants produced urine samples that exceeded the confirmation cutoff used in federal testing. In another trial, participants took a full-spectrum hemp extract with just 0.02% THC three times daily for four weeks. Six of 14 participants exceeded the federal drug testing confirmation threshold.
If you face workplace or athletic drug testing, even legal, low-THC CBD products carry a real risk of triggering a positive result. CBD isolate products are the safest option, but given the labeling accuracy problems across the industry, no consumer product comes with a guarantee.
Who Might Feel “Off” From CBD
Some people report feeling slightly drowsy, lightheaded, or mentally foggy after taking CBD, especially at higher doses. This isn’t a high in the way THC produces one. CBD can cause mild sedation, and at very high clinical doses, sleepiness is one of the more common side effects. If you’re sensitive to these effects or taking a large amount, you might interpret the sensation as being mildly altered. But the mechanism is fundamentally different from THC intoxication: there’s no euphoria, no distorted perception, and no impairment of judgment or coordination.
If a CBD product does make you feel genuinely high, the most likely explanation is that it contains more THC than advertised. Given that roughly a quarter of tested products don’t meet their own product-type claims, this is not an uncommon scenario.